24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
MD · Clinical

Tuberculosis Thesis Topics for MD Respiratory Medicine — 219+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 219+ MD Respiratory Medicine (Tuberculosis) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

219+MD Respiratory Medicine (Tuberculosis) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 219 titles See a full thesis plan
Tuberculosis thesis topics

219 Tuberculosis thesis topics, by speciality

This page gathers the Tuberculosis titles in our catalogue, 219 in all, drawn from 20 specialities, so you can pick the angle your department supports. The commonest designs here are prospective observational study, prospective analytical study, hospital-based cross-sectional study; 121 are marked High priority in our review.

MD Respiratory Medicine (Tuberculosis) — Thesis Title List

219 titles · instant objectives
  1. 001

    Etiological spectrum and clinical profile of pulmonary tuberculosis among elderly patients

    Respiratory Medicine Prospective analytical study Clinical Spectrum / Profile
    Objective
  2. 002

    Clinical spectrum, complications and hospital course of hospitalised patients with pulmonary tuberculosis at a tertiary care hospital

    Respiratory Medicine Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  3. 003

    Etiological spectrum and clinical profile of pulmonary tuberculosis among post-COVID patients

    Respiratory Medicine Retrospective record-based study Clinical Spectrum / Profile
    Objective
  4. 004

    Spectrum of extrapulmonary tuberculosis and diagnostic yield of CBNAAT at a tertiary care hospital

    Infectious Diseases Prospective analytical study Clinical Spectrum / Profile
    Objective
  5. 005

    Association of platelet indices with radiological extent of disease in newly diagnosed pulmonary tuberculosis

    Infectious Diseases Prospective analytical study Association / Correlation
    Objective
  6. 006

    Association of C-reactive protein with radiological extent and sputum smear grade in pulmonary tuberculosis

    Respiratory Medicine Prospective analytical study Association / Correlation
    Objective
  7. 007

    Treatment pattern and outcome of pulmonary tuberculosis in routine clinical practice

    Respiratory Medicine Prospective observational study Outcome / Prognostic
    Objective
  8. 008

    Serum procalcitonin in differentiating pulmonary tuberculosis from bacterial community-acquired pneumonia

    Respiratory Medicine Hospital-based cross-sectional study Association / Correlation
    Objective
  9. 009

    Prevalence of diabetes mellitus among newly diagnosed tuberculosis patients and its effect on sputum conversion

    Infectious Diseases Prospective interventional study Comparative / Interventional
    Objective
  10. 010

    Clinical profile and outcome of tuberculosis patients requiring intensive care

    Respiratory Medicine Prospective analytical study Association / Correlation
    Objective
  11. 011

    Comparison of CBNAAT (GeneXpert MTB/RIF) and sputum smear microscopy in the diagnosis of pulmonary tuberculosis

    Respiratory Medicine Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  12. 012

    Clinical, radiological and microbiological profile of pulmonary tuberculosis among patients with diabetes mellitus

    Respiratory Medicine Prospective comparative study Comparative / Interventional
    Objective
  13. 013

    Spirometric pattern and severity of lung function impairment in patients who have completed treatment for pulmonary tuberculosis

    Respiratory Medicine Hospital-based cross-sectional study Association / Correlation
    Objective
  14. 014

    Prevalence of rifampicin-resistant tuberculosis by CBNAAT among retreatment cases of pulmonary tuberculosis

    Respiratory Medicine Retrospective record-based study Association / Correlation
    Objective
  15. 015

    Short-term outcome and prognostic factors in tuberculosis among elderly patients

    Infectious Diseases Prospective analytical study Outcome / Prognostic
    Objective
  16. 016

    Haematological abnormalities in pulmonary tuberculosis and their change after intensive phase of antitubercular therapy

    Infectious Diseases Prospective analytical study Association / Correlation
    Objective
  17. 017

    Role of abdominal ultrasonography in diagnosis of abdominal tuberculosis at a tertiary care hospital

    Infectious Diseases Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  18. 018

    Predictors of ICU admission and in-hospital mortality among hospitalised patients with tuberculosis

    Infectious Diseases Randomized controlled trial Comparative / Interventional
    Objective
  19. 019

    Clinical course and discharge outcome of pulmonary tuberculosis among patients admitted with dyspnea at a tertiary care hospital

    Respiratory Medicine Prospective observational study Outcome / Prognostic
    Objective
  20. 020

    Diagnostic yield of CBNAAT on induced sputum versus bronchoalveolar lavage in sputum smear-negative pulmonary tuberculosis

    Respiratory Medicine Prospective observational study Diagnostic / Tool Evaluation
    Objective
  21. 021

    Factors associated with prolonged hospital stay in tuberculosis at a tertiary care hospital

    Infectious Diseases Retrospective record-based study Outcome / Prognostic
    Objective
  22. 022

    Outcome analysis of pulmonary tuberculosis among post-COVID patients in a tertiary care hospital

    Respiratory Medicine Retrospective record-based study Outcome / Prognostic
    Objective
  23. 023

    Ileocolonoscopic and histological features differentiating intestinal tuberculosis from Crohn disease

    Gastroenterology · Hepatology & Endoscopy Prospective observational study Diagnostic / Tool Evaluation
    Objective
  24. 024

    Incidence and risk factors of antitubercular therapy-induced hepatotoxicity in adults with pulmonary tuberculosis

    Gastroenterology & Hepatology Prospective observational study Outcome / Prognostic
    Objective
  25. 025

    Prevalence of latent tuberculosis infection by interferon-gamma release assay in patients with type 2 diabetes mellitus

    Endocrinology · Diabetes & Hormonal Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  26. 026

    Clinical presentation and treatment outcome of pulmonary tuberculosis in patients with and without diabetes mellitus

    Endocrinology · Diabetes & Hormonal Disorders Prospective comparative study Outcome / Prognostic
    Objective
  27. 027

    Association of undernutrition at diagnosis with lung function impairment at completion of treatment for pulmonary tuberculosis

    Respiratory Medicine Prospective analytical study Association / Correlation
    Objective
  28. 028

    Prevalence of chronic pulmonary aspergillosis by Aspergillus-specific IgG in post-tuberculosis lung disease

    Respiratory Medicine Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  29. 029

    Prevalence of diabetes mellitus and prediabetes among newly diagnosed pulmonary tuberculosis patients

    Respiratory Medicine Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  30. 030

    Treatment outcome and adverse events of bedaquiline-containing regimens in multidrug-resistant pulmonary tuberculosis

    Respiratory Medicine Prospective observational study Outcome / Prognostic
    Objective
  31. 031

    Incidence and risk factors of anti-tubercular drug-induced hepatotoxicity in pulmonary tuberculosis

    Respiratory Medicine Prospective observational study Outcome / Prognostic
    Objective
  32. 032

    Diagnostic performance of Truenat MTB compared with CBNAAT for detection of pulmonary tuberculosis

    Respiratory Medicine Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  33. 033

    Prevalence of latent tuberculosis infection by interferon-gamma release assay in patients with autoimmune rheumatic disease before immunosuppressive therapy

    Rheumatology & Immunology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  34. 034

    Diagnostic yield of urine lateral flow lipoarabinomannan assay for tuberculosis in hospitalised people living with HIV

    Infectious Diseases Hospital-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  35. 035

    Treatment outcome and adverse events of all-oral shorter regimens in rifampicin-resistant pulmonary tuberculosis

    Infectious Diseases Retrospective record-based study Outcome / Prognostic
    Objective
  36. 036

    Depression in patients with pulmonary tuberculosis and its association with treatment adherence

    Consultation-Liaison Psychiatry Hospital-based cross-sectional study Association / Correlation
    Objective
  37. 037

    Pulmonary function impairment and its correlation with 6-minute walk distance in treated pulmonary tuberculosis sequelae

    Tuberculosis & NTM Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  38. 038

    Effect of smoking on spirometric impairment in patients with post-tuberculosis lung disease

    Tuberculosis & NTM Prospective analytical study Clinical Spectrum / Profile
    Objective
  39. 039

    Spectrum of HRCT findings in post-tuberculosis lung disease and correlation with spirometry

    Tuberculosis & NTM Prospective observational study Clinical Spectrum / Profile
    Objective
  40. 040

    Prevalence of pulmonary hypertension on echocardiography in post-tuberculosis lung disease

    Pulmonary Vascular Disease Prospective analytical study Clinical Spectrum / Profile
    Objective
  41. 041

    Health-related quality of life using St George's Respiratory Questionnaire in post-tuberculosis lung disease

    Tuberculosis & NTM Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  42. 042

    DLCO impairment and its correlation with radiological extent in post-tuberculosis lung disease

    Tuberculosis & NTM Prospective observational study Diagnostic / Tool Evaluation
    Objective
  43. 043

    Causes and predictors of in-hospital mortality among patients with post-tuberculosis lung disease admitted with respiratory failure

    Respiratory Critical Care & Rehabilitation Retrospective record-based study Outcome / Prognostic
    Objective
  44. 044

    Sputum microbiological profile in patients with post-tuberculosis lung disease presenting with acute exacerbation

    Bronchiectasis & Respiratory Infections Retrospective record-based study Clinical Spectrum / Profile
    Objective
  45. 045

    Correlation of mMRC dyspnoea grade with spirometric and radiological severity in post-tuberculosis lung disease

    Tuberculosis & NTM Prospective comparative study Comparative / Interventional
    Objective
  46. 046

    Diagnostic yield of Truenat MTB Plus versus Xpert MTB/RIF Ultra on bronchoalveolar lavage in sputum-scarce suspected pulmonary tuberculosis

    Tuberculosis & NTM Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  47. 047

    Prevalence and treatment outcome of isoniazid-resistant, rifampicin-sensitive pulmonary tuberculosis under the national programme

    Tuberculosis & NTM Retrospective record-based study Outcome / Prognostic
    Objective
  48. 048

    Adverse events and treatment outcome of the BPaLM regimen in rifampicin-resistant pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  49. 049

    Prevalence of diabetes and prediabetes among newly diagnosed pulmonary tuberculosis patients and its effect on sputum conversion

    Tuberculosis & NTM Prospective observational study Association / Correlation
    Objective
  50. 050

    Spirometric patterns and quality of life one year after completion of treatment for pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Clinical Spectrum / Profile
    Objective
  51. 051

    Etiological spectrum of non-cystic fibrosis bronchiectasis and the proportion due to post-tuberculosis sequelae

    Bronchiectasis & Respiratory Infections Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  52. 052

    Chronic pulmonary aspergillosis among patients with persistent symptoms after treated pulmonary tuberculosis

    Bronchiectasis & Respiratory Infections Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  53. 053

    Prevalence and correlates of pulmonary hypertension in post-tuberculosis lung disease

    Pulmonary Vascular Disease Hospital-based cross-sectional study Association / Correlation
    Objective
  54. 054

    Baseline undernutrition by BMI and MUAC and its association with lung function after completion of treatment for drug-sensitive pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Association / Correlation
    Objective
  55. 055

    Prevalence of fluoroquinolone resistance on second-line line probe assay in rifampicin-resistant pulmonary tuberculosis

    Tuberculosis & NTM Retrospective record-based study Clinical Spectrum / Profile
    Objective
  56. 056

    QTc prolongation and its predictors in patients receiving bedaquiline-containing regimens for drug-resistant tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  57. 057

    Relapse within one year after successful treatment of drug-sensitive pulmonary tuberculosis and its predictors

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  58. 058

    Incidence and risk factors of drug-induced hepatotoxicity with first-line anti-tubercular treatment in pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  59. 059

    Time to sputum culture conversion and its predictors in rifampicin-resistant pulmonary tuberculosis on shorter oral bedaquiline-containing regimens

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  60. 060

    Undernutrition at diagnosis and post-tuberculosis lung function impairment on spirometry at completion of treatment for pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  61. 061

    TB-LAMP versus sputum smear microscopy against Xpert MTB/RIF Ultra for diagnosis of presumptive pulmonary tuberculosis

    Tuberculosis & NTM Hospital-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  62. 062

    Serum beta-D-glucan and Aspergillus-specific IgG for diagnosis of chronic pulmonary aspergillosis in post-tuberculosis lung disease

    Bronchiectasis & Respiratory Infections Hospital-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  63. 063

    Clinical and radiological predictors of poor outcome at six months in central nervous system tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  64. 064

    Clinical profile, laboratory characteristics and predictors of in-hospital mortality in adults with miliary tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  65. 065

    Perceived stigma on the Van Rie scale and depressive symptoms on PHQ-9 among patients with pulmonary tuberculosis on treatment

    Tuberculosis & NTM Hospital-based cross-sectional study Association / Correlation
    Objective
  66. 066

    Diagnostic yield of medical thoracoscopy for tuberculosis in lymphocytic exudative pleural effusion with low pleural fluid adenosine deaminase

    Pleural Diseases Prospective observational study Diagnostic / Tool Evaluation
    Objective
  67. 067

    HACOR score at one and 12 hours for predicting non-invasive ventilation failure in acute exacerbation of post-tuberculosis obstructive airway disease

    Respiratory Critical Care & Rehabilitation Prospective observational study Outcome / Prognostic
    Objective
  68. 068

    CT features of post-tuberculosis lung disease and their correlation with six-minute walk distance

    Chest Imaging Prospective observational study Association / Correlation
    Objective
  69. 069

    Role of CT enterography in differentiating intestinal tuberculosis from Crohn disease

    Abdominal Imaging Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  70. 070

    Computer-aided detection software on digital chest radiographs for pulmonary tuberculosis compared with sputum CBNAAT

    Chest Imaging Prospective observational study Diagnostic / Tool Evaluation
    Objective
  71. 071

    Prevalence of latent tuberculosis infection among healthcare workers detected by interferon-gamma release assay

    Mycobacteriology Prospective analytical study Clinical Spectrum / Profile
    Objective
  72. 072

    Diagnostic yield of CBNAAT on gastric aspirate and induced sputum in paediatric pulmonary tuberculosis

    Mycobacteriology Prospective analytical study Clinical Spectrum / Profile
    Objective
  73. 073

    Sputum smear and culture conversion at the end of intensive phase and its predictors in pulmonary tuberculosis

    Mycobacteriology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  74. 074

    Detection of isoniazid and rifampicin resistance by line probe assay in pulmonary tuberculosis isolates

    Mycobacteriology Prospective analytical study Clinical Spectrum / Profile
    Objective
  75. 075

    Determinants of treatment adherence among patients with drug-sensitive pulmonary tuberculosis under NTEP

    Mycobacteriology Community-based cross-sectional study Community / KAP
    Objective
  76. 076

    Screening for diabetes mellitus among patients with pulmonary tuberculosis and its association with sputum conversion

    Mycobacteriology Community-based cross-sectional study Community / KAP
    Objective
  77. 077

    Diagnostic accuracy of CBNAAT compared with liquid culture in extrapulmonary tuberculosis specimens

    Mycobacteriology Analytical cross-sectional study Community / KAP
    Objective
  78. 078

    Prevalence of rifampicin resistance detected by CBNAAT among presumptive pulmonary tuberculosis patients

    Mycobacteriology Prospective analytical study Outcome / Prognostic
    Objective
  79. 079

    Knowledge, attitude and practice regarding tuberculosis infection control among healthcare workers

    Hospital Infection Control Community-based cross-sectional study Community / KAP
    Objective
  80. 080

    CBNAAT versus liquid culture in the diagnosis of extrapulmonary tuberculosis

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  81. 081

    Truenat MTB versus CBNAAT for detection of Mycobacterium tuberculosis and rifampicin resistance

    Mycobacteriology Prospective analytical study Comparative Study
    Objective
  82. 082

    Line probe assay for isoniazid and fluoroquinolone resistance among rifampicin-resistant tuberculosis isolates

    Mycobacteriology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  83. 083

    Diagnostic utility of CBNAAT on gastric aspirate in childhood pulmonary tuberculosis

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  84. 084

    Truenat MTB Plus on extrapulmonary specimens for detection of tuberculosis and rifampicin resistance against liquid culture

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  85. 085

    Xpert MTB/XDR versus second-line line probe assay for detecting fluoroquinolone and isoniazid resistance in rifampicin-resistant tuberculosis

    Mycobacteriology Prospective analytical study Comparative Study
    Objective
  86. 086

    Stool CBNAAT for the diagnosis of pulmonary tuberculosis in children unable to produce sputum

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  87. 087

    CBNAAT on bronchoalveolar lavage in sputum-scarce and smear-negative presumptive pulmonary tuberculosis against liquid culture

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  88. 088

    Diagnostic accuracy of Truenat MTB Plus compared with liquid culture in extrapulmonary tuberculosis specimens at a tertiary care hospital

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  89. 089

    Mutation patterns in rpoB, katG and inhA genes among drug-resistant Mycobacterium tuberculosis isolates and their association with clinical risk factors

    Mycobacteriology Retrospective record-based study Association / Correlation
    Objective
  90. 090

    Diagnostic yield of stool-based nucleic acid amplification testing compared with gastric aspirate for paediatric pulmonary tuberculosis

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  91. 091

    Frequency of active tuberculosis detected by CBNAAT and liquid culture of respiratory specimens among patients with newly diagnosed lung carcinoma

    Mycobacteriology Prospective observational study Clinical Spectrum / Profile
    Objective
  92. 092

    Adverse drug reactions associated with all-oral regimens for drug-resistant tuberculosis: a prospective pharmacovigilance study

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  93. 093

    Plasma linezolid trough concentrations and their association with myelosuppression in patients with drug-resistant tuberculosis

    Therapeutic Drug Monitoring Prospective observational study Prospective Study
    Objective
  94. 094

    Medication adherence and health-related quality of life in pre-extensively drug-resistant tuberculosis patients on bedaquiline- or delamanid-containing regimens

    Rational Use & Behaviour Prospective observational study Prospective Study
    Objective
  95. 095

    Association of tobacco use with tuberculosis treatment outcomes among patients registered under NTEP

    Communicable Diseases & National Programmes Retrospective record-based study Outcome / Prognostic
    Objective
  96. 096

    Self-reported tuberculosis and vulnerability factors among rural households in a field practice area

    Communicable Diseases & National Programmes Community-based cross-sectional study Association / Correlation
    Objective
  97. 097

    Treatment outcome and its predictors among drug-sensitive tuberculosis patients under the national TB elimination programme

    Communicable Diseases & National Programmes Retrospective record-based study Outcome / Prognostic
    Objective
  98. 098

    Utilisation of Nikshay Poshan Yojana and its association with weight gain among tuberculosis patients

    Communicable Diseases & National Programmes Prospective observational study Outcome / Prognostic
    Objective
  99. 099

    Household contact screening and TB preventive therapy uptake among contacts of pulmonary tuberculosis patients

    Communicable Diseases & National Programmes Prospective observational study Community / KAP
    Objective
  100. 100

    Yield of targeted universal testing with nucleic acid amplification tests for tuberculosis among vulnerable populations in a district

    Communicable Diseases & National Programmes Retrospective record-based study Clinical Spectrum / Profile
    Objective
  101. 101

    Adverse events and completion of three-month weekly isoniazid-rifapentine versus six-month isoniazid preventive therapy among household contacts of tuberculosis patients

    Communicable Diseases & National Programmes Prospective observational study Outcome / Prognostic
    Objective
  102. 102

    Out-of-pocket and catastrophic costs among patients with drug-sensitive tuberculosis under the national programme

    Health Systems & Policy Community-based cross-sectional study Association / Correlation
    Objective
  103. 103

    Receipt of Ni-kshay Mitra nutritional support under Pradhan Mantri TB Mukt Bharat Abhiyaan and its association with treatment outcome among tuberculosis patients

    Communicable Diseases & National Programmes Prospective observational study Outcome / Prognostic
    Objective
  104. 104

    Patient and health system delays in diagnosis of pulmonary tuberculosis and their determinants among patients notified in a district

    Communicable Diseases & National Programmes Analytical cross-sectional study Association / Correlation
    Objective
  105. 105

    Prevalence of depression and its association with treatment adherence among patients with tuberculosis

    Geriatric & Community Mental Health Hospital-based cross-sectional study Association / Correlation
    Objective
  106. 106

    Treatment outcomes and adverse drug events among patients on the BPaLM regimen for drug-resistant tuberculosis under NTEP

    Communicable Diseases & National Programmes Prospective observational study Outcome / Prognostic
    Objective
  107. 107

    Implementation status of TB Mukt Panchayat indicators and community awareness of tuberculosis in selected gram panchayats of a rural block

    Communicable Diseases & National Programmes Community-based cross-sectional study Community / KAP
    Objective
  108. 108

    Prevalence of pulmonary tuberculosis by symptom screening, chest X-ray and CBNAAT among residents of old age homes in a district

    Communicable Diseases & National Programmes Descriptive epidemiological study Clinical Spectrum / Profile
    Objective
  109. 109

    Spirometry, six-minute walk distance and respiratory muscle strength in adults with post-tuberculosis lung disease

    Pulmonary Function Hospital-based cross-sectional study Cross-sectional Study
    Objective
  110. 110

    Vitamin D receptor FokI polymorphism and serum 25-hydroxyvitamin D levels in patients with pulmonary tuberculosis versus healthy controls

    Molecular Biochemistry Case-control study Case-Control Study
    Objective
  111. 111

    Clinico-radiological outcome of surgically managed tuberculosis of the dorsolumbar spine

    Spine Prospective observational study Outcome / Prognostic
    Objective
  112. 112

    GeneXpert MTB/RIF versus histopathology in the diagnosis of osteoarticular tuberculosis

    Musculoskeletal Oncology & Infection Hospital-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  113. 113

    Prevalence of rifampicin resistance on CBNAAT in tissue samples of spinal tuberculosis and its association with clinical outcome

    Spine Prospective observational study Association / Correlation
    Objective
  114. 114

    Role of GeneXpert on endometrial biopsy in diagnosis of genital tuberculosis in infertile women

    Infertility & Reproductive Endocrinology Hospital-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  115. 115

    Isoniazid prophylaxis and incidence of tuberculosis in kidney transplant recipients

    Kidney Transplantation Retrospective record-based study Outcome / Prognostic
    Objective
  116. 116

    Differentiation of intestinal tuberculosis from Crohn's disease: clinical, endoscopic, histological and outcome-based study

    IBD & Functional GI Prospective observational study Diagnostic Study
    Objective
  117. 117

    Validation of a clinical, endoscopic and radiological scoring model to differentiate Crohn's disease from intestinal tuberculosis

    IBD & Functional GI Prospective observational study Validation Study
    Objective
  118. 118

    Tuberculosis reactivation in patients receiving immune checkpoint inhibitors in a high tuberculosis burden setting

    Immunotherapy & Targeted Therapy Prospective observational study Prospective Study
    Objective
  119. 119

    Clinical profile, organ support needs and outcome of critically ill patients with tuberculosis admitted to the ICU

    ICU Infections Prospective observational study Prospective Study
    Objective
  120. 120

    Xpert MTB/RIF Ultra on intraoperative tissue for diagnosis of spinal tuberculosis compared with culture and histopathology

    CNS Infections Prospective diagnostic study Diagnostic Accuracy Study
    Objective
  121. 121

    Genitourinary tuberculosis: clinical profile, diagnostic yield and outcome of medical and surgical management

    Urinary Infections Prospective observational study Descriptive Study
    Objective
  122. 122

    Demographic and clinical spectrum of pulmonary tuberculosis with emphasis on rifampicin resistance detected by CBNAAT at a tertiary care hospital

    Respiratory Medicine Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  123. 123

    Clinical spectrum and hospital course of tuberculosis in adult patients at a tertiary care hospital

    Infectious Diseases Prospective analytical study Clinical Spectrum / Profile
    Objective
  124. 124

    Burden of complications and mortality predictors in tuberculosis at a tertiary care hospital

    Infectious Diseases Prospective observational study Outcome / Prognostic
    Objective
  125. 125

    Hypoalbuminaemia and nutritional status as predictors of treatment outcome in pulmonary tuberculosis

    Respiratory Medicine Retrospective record-based study Association / Correlation
    Objective
  126. 126

    Diagnostic yield of CBNAAT (GeneXpert) on bronchoalveolar lavage in sputum-negative pulmonary tuberculosis

    Infectious Diseases Randomized controlled trial Comparative / Interventional
    Objective
  127. 127

    Role of HRCT chest in diagnosis of sputum smear-negative pulmonary tuberculosis

    Respiratory Medicine Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  128. 128

    Correlation of sputum smear grading with radiological extent of disease in pulmonary tuberculosis

    Respiratory Medicine Retrospective record-based study Association / Correlation
    Objective
  129. 129

    Clinical profile and predictors of complications in patients with tuberculosis at a tertiary care hospital

    Infectious Diseases Hospital-based cross-sectional study Outcome / Prognostic
    Objective
  130. 130

    Clinical presentation, sites of involvement and treatment outcome of abdominal tuberculosis in adults

    Gastroenterology & Hepatology Prospective observational study Clinical Spectrum / Profile
    Objective
  131. 131

    Incidence of tuberculosis reactivation in inflammatory bowel disease patients receiving anti-TNF therapy

    Gastroenterology & Hepatology Retrospective record-based study Outcome / Prognostic
    Objective
  132. 132

    Etiological spectrum and clinical profile of primary adrenal insufficiency with emphasis on adrenal tuberculosis

    Endocrinology · Diabetes & Hormonal Disorders Prospective observational study Clinical Spectrum / Profile
    Objective
  133. 133

    Prevalence of bronchiectasis on HRCT in patients with treated pulmonary tuberculosis and persistent respiratory symptoms

    Respiratory Medicine Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  134. 134

    Prevalence of pulmonary hypertension on echocardiography in post-tuberculosis lung disease and its correlation with spirometric impairment

    Respiratory Medicine Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  135. 135

    Prevalence and etiological pattern of anaemia in patients with newly diagnosed pulmonary tuberculosis

    Hematology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  136. 136

    Association of baseline undernutrition with treatment outcome in adults with drug-sensitive pulmonary tuberculosis

    Infectious Diseases Prospective observational study Association / Correlation
    Objective
  137. 137

    Prevalence of latent tuberculosis infection by interferon-gamma release assay among patients on maintenance haemodialysis

    Infectious Diseases Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  138. 138

    Diagnostic yield of Xpert MTB/RIF Ultra on gastric aspirate in childhood pulmonary tuberculosis

    Paediatric Infectious Diseases Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  139. 139

    Nicotine dependence on the Fagerstrom Test and readiness to quit among patients with pulmonary tuberculosis on treatment

    Substance Use Disorders Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  140. 140

    Depressive symptoms on PHQ-9 and their associated factors among adults on treatment for pulmonary tuberculosis

    Consultation-Liaison Psychiatry Hospital-based cross-sectional study Association / Correlation
    Objective
  141. 141

    Clinical profile of cutaneous tuberculosis and response to anti-tubercular therapy

    Infections Prospective observational study Descriptive Study
    Objective
  142. 142

    Prevalence of chronic pulmonary aspergillosis in patients with post-tuberculosis lung disease

    Bronchiectasis & Respiratory Infections Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  143. 143

    Prevalence of chronic hypoxaemic respiratory failure and long-term oxygen requirement in post-tuberculosis lung disease

    Respiratory Critical Care & Rehabilitation Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  144. 144

    Prevalence of nocturnal hypoxaemia and sleep-disordered breathing in post-tuberculosis lung disease

    Sleep Medicine Prospective observational study Association / Correlation
    Objective
  145. 145

    Prevalence and risk factors of post-tuberculosis lung disease among patients who completed anti-tubercular treatment

    Tuberculosis & NTM Community-based cross-sectional study Community / KAP
    Objective
  146. 146

    Effect of pulmonary rehabilitation on exercise capacity and quality of life in post-tuberculosis lung disease

    Respiratory Critical Care & Rehabilitation Randomized controlled trial Comparative / Interventional
    Objective
  147. 147

    Undernutrition and nutritional support under Ni-kshay Poshan Yojana in relation to treatment outcome of drug-sensitive pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Association / Correlation
    Objective
  148. 148

    Clinical profile and species distribution of nontuberculous mycobacterial lung disease among patients evaluated for drug-resistant tuberculosis

    Tuberculosis & NTM Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  149. 149

    Yield of chest radiography with computer-aided detection for active case finding of tuberculosis among household contacts

    Tuberculosis & NTM Community-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  150. 150

    Uptake and completion of tuberculosis preventive therapy among household contacts of pulmonary tuberculosis patients

    Tuberculosis & NTM Prospective observational study Community / KAP
    Objective
  151. 151

    Factors associated with loss to follow-up among patients with drug-resistant tuberculosis at a tertiary care centre

    Tuberculosis & NTM Retrospective record-based study Association / Correlation
    Objective
  152. 152

    Effect of pulmonary rehabilitation on six-minute walk distance and dyspnoea in post-tuberculosis lung disease

    Respiratory Critical Care & Rehabilitation Prospective interventional study Comparative / Interventional
    Objective
  153. 153

    Chest radiograph scoring and its correlation with spirometric impairment and exercise capacity in post-tuberculosis lung disease

    Tuberculosis & NTM Hospital-based cross-sectional study Association / Correlation
    Objective
  154. 154

    Diagnostic accuracy of urine lateral flow lipoarabinomannan in adults living with HIV with suspected tuberculosis

    Tuberculosis & NTM Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  155. 155

    Incidence and risk factors of paradoxical reactions during treatment of tuberculous lymphadenitis and pleural tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  156. 156

    Smoking cessation during anti-tubercular treatment and its association with treatment outcome among smokers with pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Association / Correlation
    Objective
  157. 157

    Clinical profile and treatment outcome of pulmonary tuberculosis in people living with HIV at a tertiary care centre

    Tuberculosis & NTM Prospective observational study Clinical Spectrum / Profile
    Objective
  158. 158

    Prevalence of active tuberculosis among patients with type 2 diabetes screened by symptoms and chest radiography at a tertiary care hospital

    Tuberculosis & NTM Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  159. 159

    Clinical, radiological and microbiological profile of pulmonary tuberculosis in elderly patients compared with younger adults

    Tuberculosis & NTM Prospective comparative study Clinical Spectrum / Profile
    Objective
  160. 160

    Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection in patients being evaluated for biologic therapy

    Tuberculosis & NTM Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  161. 161

    Chest CT findings in sputum-negative suspected pulmonary tuberculosis and their correlation with bronchoscopic microbiological confirmation

    Tuberculosis & NTM Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  162. 162

    Change in health-related quality of life during treatment of drug-resistant pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Outcome / Prognostic
    Objective
  163. 163

    Clinico-radiological profile of endobronchial tuberculosis and development of bronchostenosis on follow-up bronchoscopy

    Tuberculosis & NTM Prospective observational study Clinical Spectrum / Profile
    Objective
  164. 164

    Serum vitamin D deficiency and its association with sputum conversion in newly diagnosed pulmonary tuberculosis

    Tuberculosis & NTM Prospective analytical study Association / Correlation
    Objective
  165. 165

    Anaemia at diagnosis and its association with sputum conversion and treatment outcome in drug-sensitive pulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Association / Correlation
    Objective
  166. 166

    Clinical profile and outcome of secondary spontaneous pneumothorax in post-tuberculosis lung disease

    Pleural Diseases Prospective observational study Outcome / Prognostic
    Objective
  167. 167

    Clinical and laboratory determinants of rifampicin resistance and treatment response in Xpert-confirmed extrapulmonary tuberculosis

    Tuberculosis & NTM Prospective observational study Association / Correlation
    Objective
  168. 168

    Prevalence of latent tuberculosis infection by interferon-gamma release assay among kidney transplant candidates

    Tuberculosis & NTM Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  169. 169

    Serum IL-6 and TNF-alpha levels in pulmonary tuberculosis and their association with radiological extent and sputum smear grade

    Tuberculosis & NTM Hospital-based cross-sectional study Association / Correlation
    Objective
  170. 170

    Health literacy and its association with treatment adherence among tuberculosis patients with diabetes or other comorbidities

    Tuberculosis & NTM Hospital-based cross-sectional study Community / KAP
    Objective
  171. 171

    Clinical predictors of unfavourable treatment outcome among adults with drug-sensitive pulmonary tuberculosis under the national programme

    Tuberculosis & NTM Retrospective record-based study Outcome / Prognostic
    Objective
  172. 172

    Fluorescein diacetate vital staining versus liquid culture for monitoring bacteriological response in drug-resistant pulmonary tuberculosis on longer regimens

    Tuberculosis & NTM Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  173. 173

    Clinical spectrum, site distribution and treatment outcome of tuberculosis in adolescents aged 10 to 19 years at a tertiary care centre

    Tuberculosis & NTM Retrospective record-based study Clinical Spectrum / Profile
    Objective
  174. 174

    Diagnostic accuracy of Xpert MTB/RIF on synovial fluid and tissue for non-spinal osteoarticular tuberculosis against a composite reference standard

    Tuberculosis & NTM Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  175. 175

    Catastrophic costs and coping strategies among patients with drug-sensitive tuberculosis treated under the National TB Elimination Programme

    Tuberculosis & NTM Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  176. 176

    Yield of symptom and chest radiograph screening for pulmonary tuberculosis among elderly residents of old age homes

    Tuberculosis & NTM Community-based cross-sectional study Community / KAP
    Objective
  177. 177

    Treatment outcomes of patients with tuberculosis notified by a private hospital through a patient-provider support agency compared with public-sector notifications

    Tuberculosis & NTM Retrospective record-based study Outcome / Prognostic
    Objective
  178. 178

    Effect of pharmacist-led counselling on treatment adherence and cough hygiene practices in patients with multidrug-resistant tuberculosis

    Tuberculosis & NTM Prospective interventional study Comparative / Interventional
    Objective
  179. 179

    MRI spectrum of spinal tuberculosis and its correlation with neurological deficit

    Musculoskeletal Imaging Prospective observational study Association / Correlation
    Objective
  180. 180

    Spectrum of ultrasonographic and CT findings in abdominal tuberculosis with microbiological or histopathological confirmation

    Abdominal Imaging Prospective observational study Clinical Spectrum / Profile
    Objective
  181. 181

    CT features of mediastinal lymphadenopathy differentiating tuberculosis from sarcoidosis with EBUS-TBNA correlation

    Chest Imaging Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  182. 182

    HRCT features differentiating non-tuberculous mycobacterial lung disease from post-primary pulmonary tuberculosis

    Chest Imaging Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  183. 183

    Clinical and microbiological profile of tuberculosis in patients with HIV co-infection

    Mycobacteriology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  184. 184

    Patient and health system delay in diagnosis of pulmonary tuberculosis and its determinants

    Mycobacteriology Analytical cross-sectional study Community / KAP
    Objective
  185. 185

    Comparison of Ziehl-Neelsen staining and LED fluorescence microscopy with culture for diagnosis of pulmonary tuberculosis

    Mycobacteriology Hospital-based cross-sectional study Outcome / Prognostic
    Objective
  186. 186

    Urine lipoarabinomannan assay for tuberculosis in HIV-infected patients

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  187. 187

    CBNAAT on synovial fluid and tissue in suspected osteoarticular tuberculosis

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  188. 188

    Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis among healthcare workers

    Mycobacteriology Hospital-based cross-sectional study Comparative Study
    Objective
  189. 189

    Genital tuberculosis in infertile women: endometrial biopsy CBNAAT, culture and histopathology

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  190. 190

    Bacterial co-infection in sputum of newly diagnosed pulmonary tuberculosis patients

    Mycobacteriology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  191. 191

    Loop-mediated isothermal amplification for detection of Mycobacterium tuberculosis in sputum

    Molecular & Rapid Diagnostics Prospective analytical study Diagnostic Accuracy
    Objective
  192. 192

    Time to MGIT culture positivity and its association with sputum smear grade and treatment outcome in pulmonary tuberculosis

    Mycobacteriology Prospective observational study Association / Correlation
    Objective
  193. 193

    Latent tuberculosis infection by interferon-gamma release assay among household contacts of pulmonary tuberculosis patients

    Mycobacteriology Community-based cross-sectional study Clinical Spectrum / Profile
    Objective
  194. 194

    Sputum quality (salivary versus mucopurulent) and its effect on smear microscopy and CBNAAT positivity in presumptive pulmonary tuberculosis

    Mycobacteriology Prospective analytical study Association / Correlation
    Objective
  195. 195

    MPT64 antigen immunochromatographic test for rapid identification of Mycobacterium tuberculosis complex from positive liquid cultures

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  196. 196

    CBNAAT on urine and urine culture in suspected genitourinary tuberculosis

    Mycobacteriology Prospective analytical study Diagnostic Accuracy
    Objective
  197. 197

    Active case finding for pulmonary tuberculosis by symptom screening and CBNAAT among household contacts of notified patients

    Mycobacteriology Community-based cross-sectional study Clinical Spectrum / Profile
    Objective
  198. 198

    Semi-quantitative bacillary load on CBNAAT and its correlation with sputum smear grade and radiological extent of pulmonary tuberculosis

    Mycobacteriology Prospective analytical study Association / Correlation
    Objective
  199. 199

    Latent tuberculosis infection by interferon-gamma release assay among patients with rheumatic diseases before biologic or immunosuppressive therapy

    Mycobacteriology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  200. 200

    Bedaquiline and linezolid resistance-associated mutations among rifampicin-resistant Mycobacterium tuberculosis isolates by targeted next-generation sequencing

    Mycobacteriology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  201. 201

    Changing distribution of extrapulmonary tuberculosis sites and CBNAAT positivity across specimen types received at a tertiary care laboratory

    Mycobacteriology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  202. 202

    Trends in first-line and second-line drug resistance by line probe assay among Mycobacterium tuberculosis isolates at an intermediate reference laboratory

    Mycobacteriology Retrospective record-based study Association / Correlation
    Objective
  203. 203

    Cost of illness of drug-resistant tuberculosis from the patient perspective

    Pharmacoeconomics Prospective observational study Pharmacoeconomic Study
    Objective
  204. 204

    Prevalence of latent tuberculosis infection by interferon-gamma release assay and its occupational risk factors among health care workers

    Occupational Health Hospital-based cross-sectional study Association / Correlation
    Objective
  205. 205

    Perceived stigma and its association with treatment adherence among patients with pulmonary tuberculosis in a rural block

    Communicable Diseases & National Programmes Community-based cross-sectional study Association / Correlation
    Objective
  206. 206

    Adherence to anti-tubercular treatment monitored through 99DOTS and its determinants among drug-sensitive tuberculosis patients

    Communicable Diseases & National Programmes Prospective observational study Outcome / Prognostic
    Objective
  207. 207

    Receipt of Ni-kshay Poshan Yojana benefits and its association with treatment outcomes among drug-sensitive tuberculosis patients

    Communicable Diseases & National Programmes Retrospective record-based study Association / Correlation
    Objective
  208. 208

    Willingness and practices of private community pharmacists in referral of presumptive tuberculosis patients to the national programme

    Communicable Diseases & National Programmes Analytical cross-sectional study Community / KAP
    Objective
  209. 209

    Knowledge of tuberculosis and silicosis and use of respiratory protection among stone quarry workers in a rural district

    Occupational Health Community-based cross-sectional study Community / KAP
    Objective
  210. 210

    Serum vitamin D levels in patients with tuberculosis compared with household contacts

    Vitamin D & Calcium Case-control study Case-Control Study
    Objective
  211. 211

    Clinical profile and outcome of abdominal tuberculosis presenting as acute abdomen

    Trauma & Emergency Surgery Prospective observational study Clinical Spectrum / Profile
    Objective
  212. 212

    Outcome of antitubercular therapy alone in non-operatively managed spinal tuberculosis without neurological deficit

    Spine Prospective observational study Outcome / Prognostic
    Objective
  213. 213

    Incidence, presentation and outcome of tuberculosis after kidney transplantation

    Kidney Transplantation Retrospective record-based study Clinical Spectrum / Profile
    Objective
  214. 214

    Clinical profile of gastrointestinal tuberculosis and outcome of anti-tubercular therapy

    IBD & Functional GI Prospective observational study Prospective Study
    Objective
  215. 215

    Outcome of biosimilar infliximab in inflammatory bowel disease and incidence of tuberculosis reactivation

    IBD & Functional GI Prospective observational study Prospective Study
    Objective
  216. 216

    Prevalence of latent tuberculosis in inflammatory bowel disease before anti-TNF therapy using IGRA and chest imaging

    IBD & Functional GI Hospital-based cross-sectional study Cross-sectional Study
    Objective
  217. 217

    CT enterography in the diagnosis of small bowel tuberculosis

    Small Bowel & Malabsorption Prospective diagnostic study Diagnostic Accuracy Study
    Objective
  218. 218

    Outcome of surgical management of spinal tuberculosis with neurological deficit

    Spine Prospective observational study Prospective Study
    Objective
  219. 219

    Outcome of augmentation cystoplasty for small-capacity bladder due to tuberculosis and neurogenic causes

    Reconstructive Urology Prospective observational study Prospective Study
    Objective

MD Respiratory Medicine (Tuberculosis) thesis — frequently asked questions

How many MD Respiratory Medicine (Tuberculosis) thesis topics are listed here?

219+ MD Respiratory Medicine (Tuberculosis) thesis topics are listed on this page, organised by subsection of the Respiratory Medicine (Tuberculosis) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Respiratory Medicine (Tuberculosis) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, MD and FCPS Respiratory Medicine (Tuberculosis) candidates?

Yes — these Respiratory Medicine (Tuberculosis) dissertation titles are aligned with NMC, NBE and DNB Respiratory Medicine (Tuberculosis) curricula and are suitable for MD Respiratory Medicine (Tuberculosis), DNB Respiratory Medicine (Tuberculosis) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp